Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,948 | $3,932 | $4,283 | $4,474 |
| - Cash | $49 | $46 | $29 | $27 |
| + Debt | $0 | $129 | $0 | $114 |
| Enterprise Value | $3,899 | $4,015 | $4,253 | $4,561 |
| Revenue | $210 | $160 | $155 | $199 |
| % Growth | 31.8% | 3.1% | -22.2% | – |
| Gross Profit | $148 | $105 | $90 | $108 |
| % Margin | 70.2% | 65.9% | 58.4% | 54.4% |
| EBITDA | $84 | $31 | $30 | $33 |
| % Margin | 39.9% | 19.5% | 19.5% | 16.4% |
| Net Income | $58 | $22 | $18 | $23 |
| % Margin | 27.6% | 13.5% | 11.7% | 11.7% |
| EPS Diluted | 1.13 | 0.42 | 0.35 | 1.81 |
| % Growth | 169% | 20% | -80.7% | – |
| Operating Cash Flow | $73 | $9 | $19 | $73 |
| Capital Expenditures | -$18 | -$13 | -$8 | -$28 |
| Free Cash Flow | $56 | -$3 | $11 | $45 |